| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.62 | 0.02 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.13 | 0.03 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.03 |